• In patients with LMCAD revascularized by PCI or CABG, the risk of all-cause and CV mortality, MI and stroke was not different, but the risk of repeated revascularization was higher in PCI-group, at long-term follow-up.
• Since the hard individual endpoint were not different among patients revascularized by PCI or CABG, the decision of the optimal revascularization should be tailored on patient characteristics and not categorically taken.
• The impact of improvement in technology DES-platform, ancillary supporting techniques, such as physiology and coronary imaging, medical therapy, needs to be further investigated in future studies.

中文翻译：

---

经皮冠状动脉介入术与冠状动脉旁路移植术：战斗仍在继续

• 在通过 PCI 或 CABG 进行血运重建的 LMCAD 患者中，全因和心血管死亡率、MI 和卒中的风险没有差异，但在长期随访中，PCI 组重复血运重建的风险更高。
• 由于通过 PCI 或 CABG 血运重建的患者的硬个体终点没有差异，最佳血运重建的决定应根据患者特征量身定制，而不是一概而论。
• DES 平台技术改进的影响、辅助支持技术，如生理学和冠状动脉成像、医学治疗，需要在未来的研究中进一步研究。